Inflammation and fibrogenesis in steatohepatitis Hideki FujiiNorifumi Kawada Review 07 February 2012 Pages: 215 - 225
Biopsy interpretation of colonic biopsies when inflammatory bowel disease is excluded Tze S. KhorHiroshi FujitaGregory Y. Lauwers Review 10 February 2012 Pages: 226 - 248
Combination of angiotensin II receptor blockers promotes proton pump inhibitor-based healing of reflux esophagitis Hiroto MiwaMichio HongoThe J-FAST Group Original Article—Alimentary Tract 01 November 2011 Pages: 249 - 255
The proximodistal aggravation of colitis depends on substance P released from TRPV1-expressing sensory neurons Matthias A. EngelMohammad KhalilPeter W. Reeh Original Article—Alimentary Tract 12 November 2011 Pages: 256 - 265
Preclinical study of the DNA repair inhibitor Dbait in combination with chemotherapy in colorectal cancer Flavien DevunGuilhem BousquetMarie Dutreix Original Article-Alimentary Tract 09 November 2011 Pages: 266 - 275
A large-scale nationwide multicenter prospective observational study of triple therapy using rabeprazole, amoxicillin, and clarithromycin for Helicobacter pylori eradication in Japan Toshio FujiokaNobuo AoyamaKoji Yakabi Original Article—Alimentary Tract 09 November 2011 Pages: 276 - 283
Rikkunshito improves symptoms in PPI-refractory GERD patients: a prospective, randomized, multicenter trial in Japan Kazunari TominagaRyuichi Iwakiriand the GERD 4 Study Group Original Article—Alimentary Tract 15 November 2011 Pages: 284 - 292
Usefulness of differentiating metabolic syndrome into visceral fat type and subcutaneous fat type using ultrasonography in Japanese males Masahiro SogabeToshiya OkahisaAkira Yamanoi Original Article—Liver, Pancreas, and Biliary Tract 09 November 2011 Pages: 293 - 299
Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients Takuya IwamotoShuji TeraiIsao Sakaida Original Article—Liver, Pancreas, and Biliary Tract 09 November 2011 Pages: 300 - 312
The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study Yoshiyuki NaraharaHidenori KanazawaKiwamu Okita Original Article—Liver, Pancreas, and Biliary Tract 25 October 2011 Pages: 313 - 320
Glycogen synthase kinase 3β inhibition sensitizes pancreatic cancer cells to gemcitabine Takeo ShimasakiYasuhito IshigakiYoshiharu Motoo Original Article—Liver, Pancreas, and Biliary Tract 01 November 2011 Pages: 321 - 333
Reducing Peg-IFN doses causes later virologic response or no response in HCV genotype 1 patients treated with Peg-IFN alfa-2b plus ribavirin Tsugiko OzeNaoki HiramatsuTetsuo Takehara Original Article—Liver, Pancreas, and Biliary Tract 23 November 2011 Pages: 334 - 342
Early evaluation of transcatheter arterial chemoembolization-refractory hepatocellular carcinoma Kenya YamanakaEtsuro HatanoShinji Uemoto Rapid Communication 21 December 2011 Pages: 343 - 346
Shall we use endoscopic submucosal dissection for every gastric neoplasia? László CzakóViktória TerzinTibor Szalóki Letter to the Editor 05 January 2012 Pages: 347 - 348
Reply to the letter by L. Czakó et al. regarding “Endoscopic submucosal dissection as a treatment for gastric noninvasive neoplasia: a multicenter study by Osaka University ESD Study Group” Motohiko KatoTsutomu NishidaTetsuo Takehara Letter to the Editor 11 January 2012 Pages: 349 - 349